Northzone, an early stage venture capital fund, led a funding round round in Idoven, a pioneering health tech company advancing early detection and precision medicine of cardiovascular disease, with participation from Insight Partners, Hambro Perks, Pau Gasol, Adam Chekroud, and Luis Sanz. Financial terms were not disclosed. "Idoven is already having a big impact on how cardiovascular health is measured, paving the way for enhanced patient outcomes. While Idoven has grown significantly, there is still a lot to come to deliver the vision of bringing expert-level diagnosis wherever the patient needs it, towards the goal of having a cardiologist in your pocket. We believe Manuel and his team of medical and AI experts have a chance to build a category-defining company, and we are excited to deepen Northzone commitment with this latest investment," Michiel Kotting, Northzone Partner.